Robert Bindert Huizinga is EVP of Research of Aurinia Pharmaceuticals Inc.. Currently has a direct ownership of 69,379 shares of AUPH, which is worth approximately $626,492. The most recent transaction as insider was on Mar 02, 2022, when has been sold 4,849 shares (Common Stock) at a price of $12.01 per share, resulting in proceeds of $58,236. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 69.4K
0% 3M change
0% 12M change
Total Value Held $626,492

Robert Bindert Huizinga Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 02 2022
SELL
Open market or private sale
$58,236 $12.01 p/Share
4,849 Reduced 6.53%
69,379 Common Stock
Mar 02 2022
BUY
Grant, award, or other acquisition
-
8,500 Added 10.27%
74,228 Common Stock
Oct 25 2021
SELL
Open market or private sale
$3,867,500 $29.75 p/Share
130,000 Reduced 66.42%
65,728 Common Stock
Oct 25 2021
BUY
Exercise of conversion of derivative security
$304,000 $3.2 p/Share
95,000 Added 32.68%
195,728 Common Stock
Sep 21 2021
SELL
Open market or private sale
$775,450 $23.86 p/Share
32,500 Reduced 24.39%
100,728 Common Stock
Sep 21 2021
BUY
Exercise of conversion of derivative security
$79,237 $2.92 p/Share
27,136 Added 16.92%
133,228 Common Stock
Sep 14 2021
SELL
Open market or private sale
$489,375 $21.75 p/Share
22,500 Reduced 17.5%
106,092 Common Stock
Sep 10 2021
SELL
Open market or private sale
$198,000 $19.8 p/Share
10,000 Reduced 7.22%
128,592 Common Stock
Sep 07 2021
SELL
Open market or private sale
$91,500 $18.3 p/Share
5,000 Reduced 3.48%
138,592 Common Stock
May 11 2021
BUY
Exercise of conversion of derivative security
$120,800 $3.02 p/Share
40,000 Added 21.79%
143,592 Common Stock
RBH

Robert Bindert Huizinga

EVP of Research
Victoria, A1

Track Institutional and Insider Activities on AUPH

Follow Aurinia Pharmaceuticals Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AUPH shares.

Notify only if

Insider Trading

Get notified when an Aurinia Pharmaceuticals Inc. insider buys or sells AUPH shares.

Notify only if

News

Receive news related to Aurinia Pharmaceuticals Inc.

Track Activities on AUPH